表紙
市場調査レポート

初期段階のドラッグデリバリー技術:新規・新興企業のプロファイル

Emerging Drug Delivery Technologies, Profiles of Start-ups and Early-Stage Companies

発行 MCD Group, LLC 商品コード 269546
出版日 ページ情報 英文 136 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
初期段階のドラッグデリバリー技術:新規・新興企業のプロファイル Emerging Drug Delivery Technologies, Profiles of Start-ups and Early-Stage Companies
出版日: 2013年05月31日 ページ情報: 英文 136 Pages
概要

当レポートは、創業間もない企業や小規模企業に注目して新しいドラッグデリバリー技術について調査・モニタリングしたもので、詳細な技術説明、開発状況/パイプライン製品、特許・出版物、提携・資金調達の機会、事業開発&ライセンシング合意などの情報をまとめた各企業のプロファイルを提供しており、概略下記の構成でお届けします。

エグゼクティブサマリー

62社のプロファイル

  • Affinity Therapeutics
  • Aquarius Biotechnologies
  • Axxia Pharmaceuticals
  • Blend Therapeutics
  • Clearside Biomedical
  • Cristal Delivery BV
  • DLVR Therapeutics
  • EnduRx Pharmaceuticals
  • Ekteino Laboratories
  • Extend Biosciences
  • Inspiro Medical
  • KAER Biotherapeutics
  • Lauren Sciences, LLC
  • LyoGo LLC
  • Orbis Biosciences
  • ProLynx LLC
  • Prometheon Pharma, LLC
  • Qrono, Inc.
  • scPharmaceuticals, LLC
  • Vaxxas

追加の42社

目次

MCD Group continuously researches and monitors emerging drug delivery technologies and has compiled this report to profile some of the innovative developments at younger, emerging companies. The report focuses on start-ups and smaller companies that tend to be less well known, but are expected to gain momentum as they advance their technologies and produce significant clinical data. All of the companies profiled have interest in forming new partnerships or receiving funding to enable further development and eventual commercialization of their technologies.

The report features profiles of 62 companies, a majority of which were founded in the past five years. Most are located in the United States; however a few profiled companies are based in Canada, Europe, and Australia. Approximately 50% of the companies are affiliated with a University, and ten companies have initiated human clinical trials.

Collectively, the emerging companies profiled in this report are focused on 11 different therapeutic categories. Oncology is the leading focus among companies investigated, and approximately 25 percent of the companies profiled are developing proprietary technologies designed to improve delivery of macromolecules/biologics. Another 25 percent of the companies are focused on novel delivery devices, ranging from inhalation and nasal devices, to more patient-friendly injectable systems. All of the companies investigated are developing technologies that could potentially transform drug delivery in one or more therapeutic areas.

For each company profiled, the following information is provided:

  • Detailed Technology Description
  • Development Status / Pipeline Products
  • Patents and Publications
  • Partnership and Funding Opportunities
  • Business Development & Licensing Contact

Examples of Technologies Presented:

  • Mini-pump for subcutaneous delivery of IV medications
  • Targeted nanoparticle micelles
  • Antibody-targeted liposomes
  • Abuse-deterrent delivery system
  • Dry powder particle processing technology
  • Oral capsule technology for biologics
  • Nanovesicle delivery system for delivery across the blood-brain barrier
  • Timed-release intra-ocular implant device
  • Non-invasive aerosol device for brain drug delivery
  • Extracellular drug conjugate technology
  • Nanoparticles and novel device for CNS and inner ear drug delivery
  • Next-generation auto-injector technology
  • Nanopolymer drug conjugates
  • Microneedle patch system
  • Pocket-sized ultrasound delivery device
  • Biodegradable, topical drug patch

Sample of Companies Profiled

Aquarius BiotechnologiesLaserLeap
Convoy TherapeuticsOrbis Biosciences
Corinthian OphthalmicQrono, Inc.
Entrega, Inc.scPharmaceuticals
HylaPharmTheraTarget
Inspiro MedicalZetrOZ, LLC

Reasons to Buy

  • Identify early stage delivery technologies that will potentially “enable” the delivery of your therapeutic compound
  • Learn about investment opportunities with emerging companies, to gain access to promising, early stage technologies
  • Identify novel drug delivery formulations available for partnering, to enhance your product portfolio

About MCD Group, LLC

We specialize in life science industry reports and customized consulting services for pharmaceutical, biotechnology and drug delivery companies. The company's industry reports provide timely and accurate technology and market intelligence, and can serve as a valuable tool in the identification and evaluation of drug delivery product and technology partnering opportunities.

Table of Contents

Executive Summary

  • Figure 1: Featured Companies by Year Founded
  • Figure 2: Featured Early Stage Technologies by Delivery Route
    • Table 1: Sample of Emerging Parenteral DDS Companies
    • Table 2: Sample of Emerging Delivery Devices in Development
    • Table 3: Ten Novel Pipeline Products of DDS Start-ups
    • Table 4: Emerging Companies by Therapeutic Focus

Company Profiles

  • ABsize, Inc.
  • Affinity Therapeutics, LLC
  • AiroMedica, LLC
  • AlignBioscience Laboratory, LLC
  • Alitair Pharmaceuticals, Inc.
  • Aquarius Biotechnologies
  • Axxia Pharmaceuticals, LLC
  • Blend Therapeutics
  • Centrose, LLC
  • Civitas Therapeutics
  • Clearside Biomedical, Inc.
  • Convoy Therapeutics
  • Corinthian Ophthalmic, Inc.
  • Cristal Delivery, B.V.
  • Dance Pharma
  • DLVR Therapeutics
  • Ekteino Laboratories, Inc.
  • EnduRx Pharmaceuticals, Inc.
  • Engineered BioPharmaceuticals, Inc.
  • Entrega, Inc.
  • Extend Biosciences, Inc.
  • FluGen, Inc.
  • GrayBug, LLC
  • HylaPharm
  • Impel Neuropharma
  • Inspirion Delivery Technologies, LLC
  • Inspiro Medical, Ltd.
  • Intensity Therapeutics, Inc.
  • iVeena, LLC
  • KAER Biotherapeutics
  • Kala Pharmaceuticals, Inc.
  • Keystone Nano
  • LaserLeap Technologies
  • Lauren Sciences, LLC
  • LyoGo, LLC
  • Lypro Biosciences, Inc.
  • NanoMedical Systems, Inc.
  • NanoSmart Pharmaceuticals, Inc.
  • On Demand Therapeutics, Inc.
  • Orbis Biosciences, Inc.
  • OtoMagnetics & Weinberg Medical Physics
  • Oval Medical Technologies
  • PhaseRx
  • PolyActiva Pty, Ltd.
  • PolyPid, Ltd.
  • ProLynx, LLC
  • Prometheon Pharma, LLC
  • ProSolus Pharma, LP
  • Prosonix, Ltd.
  • Quiet Therapeutics
  • Qrono, Inc.
  • Ratio, Inc.
  • Respira Therapeutics, Inc.
  • scPharmaceuticals, LLC
  • SipNose, Ltd.
  • Solstice Biologics, LLC
  • SpherIngenics, Inc.
  • TheraTarget
  • Vaxxas
  • Versartis, Inc.
  • Xeris Pharmaceuticals, Inc.
  • ZetrOZ, LLC
Back to Top